Same Indication

Nivolumab vs Rivaroxaban

Nivolumab vs Rivaroxaban: Overview

This comparison examines the pharmacological differences between Nivolumab and Rivaroxaban.

Mechanism of Action

Nivolumab: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.

Rivaroxaban: Direct Factor Xa inhibitor.

Pharmacokinetics

Half-life: Nivolumab β€” 27 days; Rivaroxaban β€” 5-9 hours.

Chemical Properties

Molecular Formula: Rivaroxaban β€” C19H18ClN3O5S.

Molecular Weight: Rivaroxaban β€” 435.8820 g/mol.

Type: Nivolumab β€” Antibody; Rivaroxaban β€” Small molecule.